Sign in

NCT05700916Active, not recruitingEarly phase 1

Evaluation of Milk Polar Lipids in Dyslipidemic Adults With Abdominal Obesity

Evaluation of Milk Polar Lipids on Lipoprotein Metabolism, Inflammation, and Gut Microbiota in Dyslipidemic Adults With Abdominal Obesity

Source: ClinicalTrials.gov · Last updated 12 Aug 2026

Brief summary (registry, in English)

The major objective of this project is to examine whether daily consumption of milk polar lipids (MPLs) influences cardiometabolic risk factors.

Status (registry)
Active, not recruiting
Phase (registry)
Early phase 1
Study type
Interventional
Enrollment
130 (estimated)
First submitted
10 Jan 2023
Start date
20 Oct 2023
Primary completion date
31 Dec 2026
Lead sponsor
University of Connecticut
Diseases
Obesity
NCT number
NCT05700916

What you commit to

  • Study type: Interventional · Early phase 1
  • Planned participants: 130
  • From 20 Oct 2023 to the primary completion date, 31 Dec 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Intravenous drug use
  • Oral antibiotics use up to 1 month prior to and during study
  • Taking lipid-lowering medications (e.g., statins, fibrates)
  • Taking anti-inflammatory medications (e.g., corticosteroids)
  • Taking medications which primarily affect blood clotting (e.g., warfarin).

Other illness

  • Renal disease
  • Liver disease
  • Diabetes
  • Heart disease
  • Stroke
  • Cancer
  • Eating disorders
  • Thyroid disease
  • Autoimmune diseases
  • Chronic inflammatory diseases
  • Gallbladder disease
  • Blood clotting disorders
  • Allergy or intolerance to milk products

Lab values

  • Fasting plasma/serum triglycerides \>500 mg/dL
  • Fasting plasma/serum glucose \>126 mg/d

Other

  • Gut-associated pathologies
  • Scleroderma
  • Weight changes \>10% over last 4 weeks

Who the study is looking for

  • LDL-C ≥ 130 mg/dL
  • Waist circumference ≥ 88 cm for women, ≥ 102 cm for men
  • Aged 18 to 70 years

Age in the registry: 18 years to 70 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
University of Connecticut
Coordinator of this site? Confirm its status
StorrsUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.